222 related articles for article (PubMed ID: 36622753)
21. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
22. BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors.
Boeuf S; Bovée JV; Lehner B; van den Akker B; van Ruler M; Cleton-Jansen AM; Richter W
BMC Cancer; 2012 Oct; 12():488. PubMed ID: 23088614
[TBL] [Abstract][Full Text] [Related]
23. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
24. Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors.
Ho L; Stojanovski A; Whetstone H; Wei QX; Mau E; Wunder JS; Alman B
Cancer Cell; 2009 Aug; 16(2):126-36. PubMed ID: 19647223
[TBL] [Abstract][Full Text] [Related]
25. IDH1 Mutation Induces HIF-1
Hu X; Li L; Eid JE; Liu C; Yu J; Yue J; Trent JC
Dis Markers; 2022; 2022():7729968. PubMed ID: 35198082
[TBL] [Abstract][Full Text] [Related]
26. BAG3 promotes chondrosarcoma progression by upregulating the expression of β-catenin.
Shi H; Chen W; Dong Y; Lu X; Zhang W; Wang L
Mol Med Rep; 2018 Apr; 17(4):5754-5763. PubMed ID: 29484408
[TBL] [Abstract][Full Text] [Related]
27. COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration.
Omar R; Cooper A; Maranyane HM; Zerbini L; Prince S
Cancer Lett; 2019 Sep; 459():227-239. PubMed ID: 31202624
[TBL] [Abstract][Full Text] [Related]
28. WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis.
Lin CY; Tzeng HE; Li TM; Chen HT; Lee Y; Yang YC; Wang SW; Yang WH; Tang CH
Oncotarget; 2017 Jun; 8(24):39571-39581. PubMed ID: 28465477
[TBL] [Abstract][Full Text] [Related]
29. Visfatin Promotes the Metastatic Potential of Chondrosarcoma Cells by Stimulating AP-1-Dependent MMP-2 Production in the MAPK Pathway.
Hung SY; Lin CY; Yu CC; Chen HT; Lien MY; Huang YW; Fong YC; Liu JF; Wang SW; Chen WC; Tang CH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445345
[TBL] [Abstract][Full Text] [Related]
30. ADAMTS1 is regulated by interleukin-1beta, not by hypoxia, in chondrosarcoma.
Kalinski T; Krueger S; Sel S; Werner K; Röpke M; Roessner A
Hum Pathol; 2007 Jan; 38(1):86-94. PubMed ID: 16949904
[TBL] [Abstract][Full Text] [Related]
31. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
[TBL] [Abstract][Full Text] [Related]
34. Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours.
Boeuf S; Bovée JV; Lehner B; Hogendoorn PC; Richter W
Histopathology; 2010 Apr; 56(5):641-51. PubMed ID: 20459575
[TBL] [Abstract][Full Text] [Related]
35. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
Schrage YM; Lam S; Jochemsen AG; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Cell Mol Med; 2009 Sep; 13(9A):2843-52. PubMed ID: 18624751
[TBL] [Abstract][Full Text] [Related]
36. Biological aspects of chondrosarcoma: Leaps and hurdles.
Mery B; Espenel S; Guy JB; Rancoule C; Vallard A; Aloy MT; Rodriguez-Lafrasse C; Magné N
Crit Rev Oncol Hematol; 2018 Jun; 126():32-36. PubMed ID: 29759564
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential.
Sun R; Shen J; Gao Y; Zhou Y; Yu Z; Hornicek F; Kan Q; Duan Z
Oncotarget; 2016 Jun; 7(25):38333-38346. PubMed ID: 27223261
[TBL] [Abstract][Full Text] [Related]
38. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
39. PTEN mutation is rare in chondrosarcoma.
Lin C; Meitner PA; Terek RM
Diagn Mol Pathol; 2002 Mar; 11(1):22-6. PubMed ID: 11854598
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
